During the past decade, West London Research Unit; Brentford Lodge conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "West London Research Unit; Brentford Lodge" are "Alzheimer's Disease" (2 trials). Many other conditions were trialed in "West London Research Unit; Brentford Lodge" in a lesser frequency.

Most popular intervention types in "West London Research Unit; Brentford Lodge" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Crenezumab" (1 trials), "MABT5102A" (1 trials) and "placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "West London Research Unit; Brentford Lodge" are 2 trials for "All" genders.

Currently, there are NaN active trials in "West London Research Unit; Brentford Lodge". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in West London Research Unit; Brentford Lodge, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in West London Research Unit; Brentford Lodge, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".